""Ekso Bionics has fulfilled all of the FDA requirements that empower the company to sell the first commercial version of the Ekso exoskeleton to rehabilitation centers," he added. The sale of each exoskeleton to rehabilitation centers includes "Ekso +," a comprehensive service, financing and training program.
Investigational studies of the device at the Charter Rehabilitation Centers have just been completed. The ten-month program defined clinical protocols, and provided insights into ways to improve the device. The charter hospitals will also become the first Ekso Centers in the world, conducting ongoing research, and offering the device for the rehabilitation of their patients."